LY-3202626 | Interleukin Related interleukin-related.com

Product Name :
LY-3202626

Search keywords :
LY3202626

drugId :
null

Target Vo:
Beta-secretase 1

Target Vo Short Name :
BACE1

Moa_Name:
Beta-secretase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Eli Lilly And Company

Active Indication_Name:
Alzheimer Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
M-CSF Antibody
FGFR2 Antibody
PI3 Kinase p110 gamma Antibody (YA690): PI3 Kinase p110 gamma Antibody (YA690) is a non-conjugated and Mouse origined monoclonal antibody about 126 kDa, targeting to PI3 Kinase p110 gamma (2D10). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts